Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vomiting 23 Nausea 20 Neoplasms 10 Lymphoma, Non-Hodgkin 7 Leukemia, Myeloid, Acute 7 Breast Neoplasms 6 Multiple Myeloma 5 Sezary Syndrome 4 Primary Myelofibrosis 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Myeloproliferative Disorders 4 Mycosis Fungoides 4 Lymphoma, T-Cell, Cutaneous 4 Lymphoma, Mantle-Cell 4 Lymphoma, Large-Cell, Immunoblastic 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Follicular 4 Lymphoma, B-Cell, Marginal Zone 4 Lymphoma 4 Leukemia, Myelomonocytic, Chronic 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Leukemia, Hairy Cell 4 Hodgkin Disease 4 Burkitt Lymphoma 4 Pdgfra-Associated Chronic Eosinophilic Leukemia 3 Myelodysplastic Syndromes 3 Leukemia, Neutrophilic, Chronic 3 Leukemia, Myeloid, Chronic-Phase 3 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3 Leukemia, Myeloid, Accelerated Phase 3

Interventions

venetoclax 1 pyrotinib 1 pertuzumab 1 penpulimab 1 palbociclib 1 dalpiciclib 1 anlotinib 1 Tretinoin 1 Trastuzumab 1 Ropivacaine 1 Radiosurgery 1 Propofol 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Ondansetron 1 Morphine 1 Letrozole 1 Induction Chemotherapy 1 Fulvestrant 1 Etoricoxib 1 Docetaxel 1 Diagnostic Imaging 1 Carboplatin 1 Capecitabine 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Breast Neoplasm Female × Ondansetron × Clear all

NCT03117894 2021-06-04

PECS-2 for Breast Surgery

Umeå University

Phase NA Completed

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡